School of Medicine
Showing 1-10 of 111 Results
-
Anna Badner
Postdoctoral Research Fellow, Psychiatry
Bio I am currently a Postdoctoral Research Fellow at Stanford University in the lab of Dr. Erin Gibson. I completed my PhD at the Institute of Medical Science in the University of Toronto (2018), under the supervision of Dr. Michael Fehlings, where my thesis was focused on the peripheral inflammatory response in neurotrauma and application of immunomodulatory cell therapies to target this pathology. I subsequently spent two years as a Postdoctoral Scholar at the Sue & Bill Gross Stem Cell Research Center, University of California-Irvine (UCI), transplanting various sources of neural stem cells for traumatic brain injury. During this time, I expanded my interest in the activation of endogenous progenitors as an alternative to cell transplantation for therapeutic purposes.
-
Jean Marie Batail
Postdoctoral Research Fellow, Psychiatry
Bio I am a MD/PhD postdoctoral scholar from Rennes in France. Before arriving in Stanford, I worked in both clinical and research fields. I leaded a unit specialized in neuropsychiatric treatment resistant disorders (mainly depression, Parkinson Disease with psychiatric comorbidities and obsessive-compulsive disorder) with two residents. In this unit, I used and coordinated neuromodulations techniques such as repetititive Trancranial Magnetic Stimulation, Electroconvulsive therapy, and Deep Brain Stimulation. In the research part of my activity, my work focused on biomarkers of poor outcome of depressive disorder using clinical/neuropsychological/brain imaging assessments. In addition, I conducted research on neurofeedback applied to depression. Apart to be involved in the national coordination of this topic for psychiatric diseases (Neurofeedback section of French Association of Biological Psychiatry and Neuropsychopharmacology https://www.afpbn.org/sections/next/), I was actively involved in the development of a new generation of brain-computer interface therapies based on joint bimodal EEG-fMRI neurofeedback. In this project, I leaded the clinical research applying this new technology to depression. I am very interested in working on biomarkers of neuropsychiatric disorders and the development of personalized-targeting neuromodulation techniques.
